BioSante Pharmaceuticals to Present at Upcoming Conferences
May 30 2007 - 9:12AM
Business Wire
BioSante Pharmaceuticals (AMEX:BPA) today announced that Stephen M.
Simes, its president and chief executive officer, will present a
corporate overview and update at upcoming conferences. The
conferences are: The RedChip Small-Cap Investor Conference today,
May 30, 2007 at 10:30 a.m. local time at the Ritz Carlton in San
Francisco. The BioMed 2007 Conference on June 7th at approximately
10:00 a.m. local time at the David Intercontinental Hotel in
Tel-Aviv, Israel. The Needham Biotechnology and Medical Technology
Conference on June 13th at 8:00 a.m. local time at the New York
Palace Hotel. A live audio webcast of BioSante�s presentation at
the RedChip and Needham conferences can be accessed on the internet
by visiting www.biosantepharma.com. An archive of these
presentations will be available at the same address. These
conferences each feature companies presenting to a diverse group of
investors and analysts interested in the biotechnology and
pharmaceuticals sectors as well as industry representatives. About
BioSante Pharmaceuticals, Inc. BioSante is developing a pipeline of
hormone therapy products to treat both men and women. These hormone
therapy products are gel formulations for transdermal
administration that deliver bio-identical estradiol and
testosterone. BioSante's lead products include Elestrin� (estradiol
gel), developed through U.S. Food and Drug Administration (FDA)
approval by BioSante, indicated for the treatment of
moderate-to-severe vasomotor symptoms associated with menopause,
and LibiGel� (transdermal testosterone gel) in Phase III
development for the treatment of female sexual dysfunction (FSD).
The current market in the U.S. for estrogen and testosterone
products is approximately $2.5 billion. The company also is
developing its calcium phosphate nanotechnology (CaP) for novel
vaccines, including hepatitis B, avian flu and biodefense vaccines
for toxins such as anthrax, as well as a system for delivering
drugs via alternative routes of administration. Additional
information is available online at: www.biosantepharma.com.
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jul 2023 to Jul 2024